NCT00486356 2024-01-03
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
Phase 1 Completed
Clinical Trials
1 trialsInterventional × Gallbladder Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all